{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:41:32Z","timestamp":1758588092560,"version":"3.44.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.transproceed.2010.07.043","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T06:29:48Z","timestamp":1287728988000},"page":"2935-2937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Erythropoietin Resistance as Surrogate Marker of Graft and Patient Survival in Renal Transplantation: 3-Year Prospective Multicenter Study"],"prefix":"10.1016","volume":"42","author":[{"given":"C.","family":"Gomez-Alamillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Fern\u00e1ndez-Fresnedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Campistol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Gentil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2010.07.043_bib1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1034\/j.1600-6143.2003.00133.x","article-title":"Prevalence and management of anemia in kidney transplant recipients: a European survey","volume":"3","author":"Vanrenterghem","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.07.043_bib2","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1016\/j.transproceed.2005.10.054","article-title":"Prevalence of anemia in renal transplant patients: results from MOST, an observational trial","volume":"37","author":"Fern\u00e1ndez Fresnedo","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.07.043_bib3","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.V1341084","article-title":"Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease","volume":"13","author":"Rigatto","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2010.07.043_bib4","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1046\/j.1600-6135.2003.00224.x","article-title":"Anemia: a continuing problem following kidney transplantation","volume":"3","author":"Mix","year":"2003","journal-title":"Am J Transplant"},{"issue":"suppl 8","key":"10.1016\/j.transproceed.2010.07.043_bib5","doi-asserted-by":"crossref","first-page":"viii8","DOI":"10.1093\/ndt\/gfh1110","article-title":"Impact of pre-transplant anaemia correction and erythropoietin resistance on long-term graft survival","volume":"20","author":"Campise","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2010.07.043_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1440-1797.2007.00810.x","article-title":"Erythropoiesis-stimulating agent hyporesponsiveness","volume":"12","author":"Johnson","year":"2007","journal-title":"Nephrology"},{"key":"10.1016\/j.transproceed.2010.07.043_bib7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2006.07.006","article-title":"Anemia after renal transplantation","volume":"48","author":"Afzali","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2010.07.043_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00044011-199815010-00007","article-title":"Erythropoietin Effectiveness Index: a quantitative definition of resistance in haemodialysis patients with adequate iron stores","volume":"15","author":"Bailie","year":"1998","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.transproceed.2010.07.043_bib9","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1097\/01.ASN.0000137879.97445.6E","article-title":"Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and EPO resistance","volume":"15","author":"L\u00f3pez-G\u00f3mez","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2010.07.043_bib10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.ajkd.2005.09.013","article-title":"Challenging the validity of the EPO index","volume":"47","author":"Kaysen","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2010.07.043_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.ki.5002056","article-title":"Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants","volume":"71","author":"Solid","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2010.07.043_bib12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1600-6143.2006.01727.x","article-title":"Anemia is associated with mortality in kidney-transplanted patients: a prospective cohort study","volume":"7","author":"Molnar","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.07.043_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1053\/j.ajkd.2006.11.034","article-title":"Anemia after kidney transplantation is not completely explained by reduced kidney function","volume":"49","author":"Chadban","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2010.07.043_bib14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/TP.0b013e3181814a96","article-title":"Reduction in erythropoietin resistance after conversion from sirolimus to enteric coated mycophenolate sodium","volume":"86","author":"Augustine","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.07.043_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.ajkd.2004.08.042","article-title":"Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease?","volume":"45","author":"Kausz","year":"2005","journal-title":"Am J Kidney Dis"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510010882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510010882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:27:04Z","timestamp":1758576424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134510010882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0041134510010882"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2010.07.043","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythropoietin Resistance as Surrogate Marker of Graft and Patient Survival in Renal Transplantation: 3-Year Prospective Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2010.07.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}